A hot theme that is no less superior to AI semiconductors in the US stock market is “slimming drugs.”Stock prices of “slimming drug” brands have risen in a short period of time in the US. In Japan, where the obese population is said to be relatively small, interest is not as high as in the US, but there are domestic listed companies involved in the development of “slimming drugs,” and if commercialized, there is a possibility that overseas investors will “buy” in the same way as American brands. We will pick up 3 promising brands involved in the development of “slimming drugs” domestically.
Related stocks have skyrocketed in the US over the past year or so
“Weight loss drugs” were originally developed as therapeutic agents for patients with diabetes and obesity, etc., but when products with “slimming” effects were sold to the general public, they became a big hit.
particularlyAmericans, who say 40% of citizens are obese, have a high level of attention, and Tesla CEO Elon Musk also uses itIt is said that there are many influencers related to “slimming drugs” on SNS.It has been revealed that Horie Takafumi called Horiemon also used it in Japan。
The “slimming drug” market will grow about 16 times to 100 billion dollars (about 15 trillion yen) by 2030...